Healthcare

Initial Public Offering of Premier Research Group

2017-12-08T16:36:49+00:00

HMT advised and acted as reporting accountants to Premier Research Group on the AIM flotation in December 2004. The flotation raised £8 million before costs at a placing price of 40p per share, and was accompanied by the raising of a £3.5 million banking facility from Lloyds TSB. This enabled Premier Research Group to repay its Acquisition Loans and strengthen its balance sheet. Premier Research Group was originally established in 2002 as a buy and build strategy, with [...]

Refinancing of Advanced Clinical Sciences Corporation Ltd and acquisition of CRC GmbH (Switzerland) and CRC SRL (Italy)

2017-11-30T09:20:31+00:00

HMT advised its client Advanced Clinical Research Corporation Limited (“ACSC”) in the refinancing of its growing operations and the acquisition of the pan European CRC Group. ACSC was founded in 2002 by Dr Guy Patrick, Dr Simon Yaxley and Mr Tim Carden, all of whom have extensive experience of the pharmaceutical industry. The objective of the business was to build a contract Clinical Research Organisation (“CRO”) with a global footprint in the medical clinical research market through buy [...]

Management buyout RBF Group

2017-12-08T17:02:16+00:00

HMT advised the management team in its buyout of RBF Group, the Southend on Sea based manufacturer of healthcare products and heatshields, having been recommended to management by Northern Venture Managers.  RBF Group has premises in Southend on Sea, Salford and Cambridge. The business operates in three distinct markets, manufacturing healthcare products for private consumers and the social services, heat shields for use on engine and exhaust systems, and third party manufacturing projects such as seat covers and [...]

Go to Top